Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway

References

• Klatte T, Stewart GD. Renal cell carcinoma: standards and controversies. World J Urol. 2018;36(12):1889–1890.
   PubMed Web of Science ®Google Scholar
• Berglund A, Amankwah EK, Kim YC, et al. Influence of gene expression on survival of clear cell renal cell carcinoma. Cancer Med. 2020;9(22):8662–8675.
   PubMed Web of Science ®Google Scholar
• Lin H, Keriel A, Morales CR, et al. Divergent N-terminal sequences target an inducible testis deubiquitinating enzyme to distinct subcellular structures. Mol Cell Biol. 2000;20(17):6568–6578.
   PubMed Web of Science ®Google Scholar
• Chuang SJ, Cheng SC, Tang HC, et al. 6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2. Sci Rep. 2018;8(1):3102.
   PubMedGoogle Scholar
• Zhang LN, Zhang DD, Yang L, et al. Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis. FEBS J. 2021;288(5):1447–1456.
   PubMed Web of Science ®Google Scholar
• Yan X, Han D, Chen Z, et al. RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells. Cancer Cell Int. 2020;20:505.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhao L, Zhang T, et al. Curcumin negatively regulates cigarette smoke-induced renal cell carcinoma epithelial-mesenchymal transition through the ERK5/AP-1 pathway. Onco Targets Ther. 2020;13:9689–9700.
   PubMed Web of Science ®Google Scholar
• Chen W, Wang J, Wang X, et al. Knockdown of hypoxia-inducible factor 1-alpha (HIF1α) interferes with angiopoietin-like protein 2 (ANGPTL2) to attenuate high glucose-triggered hypoxia/reoxygenation injury in cardiomyocytes. Bioengineered. 2022;13(1):1476–1490.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
   PubMed Web of Science ®Google Scholar
• Davra V, Saleh T, Geng K, et al. Cyclophilin A inhibitor debio-025 targets Crk, reduces metastasis, and induces tumor immunogenicity in breast cancer. Mol Cancer Res. 2020;18(8):1189–1201.
   PubMed Web of Science ®Google Scholar
• Kumar S, Lu B, Davra V, et al. Crk tyrosine phosphorylation regulates PDGF-BB-inducible Src activation and breast tumorigenicity and metastasis. Mol Cancer Res. 2018;16(1):173–183.
   PubMed Web of Science ®Google Scholar
• Qin G, Wang X, Ye S, et al. NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer. Nat Commun. 2020;11(1):1669.
   PubMed Web of Science ®Google Scholar
• Cao S, Zhang S. Forkhead-box C1 attenuates high glucose-induced trophoblast cell injury during gestational diabetes mellitus via activating adenosine monophosphate-activated protein kinase through regulating fibroblast growth factor 19. Bioengineered. 2022;13(1):1174–1184.
   PubMed Web of Science ®Google Scholar
• Xie W, Sun Y, Zeng Y, et al. Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer. Bioengineered. 2022;13(1):190–205.
   PubMed Web of Science ®Google Scholar
• Xu L, Shao F. Sitagliptin protects renal glomerular endothelial cells against high glucose-induced dysfunction and injury. Bioengineered. 2022;13(1):655–666.
   PubMed Web of Science ®Google Scholar
• Li H, Wang N, Xu Y, et al. Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells. Bioengineered. 2022;13(1):1304–1319.
   PubMed Web of Science ®Google Scholar
• Metzig M, Nickles D, Falschlehner C, et al. An RNAi screen identifies USP2 as a factor required for TNF-α-induced NF-κB signaling. Int J Cancer. 2011;129(3):607–618.
   PubMed Web of Science ®Google Scholar
• Shen E, Zhang J, Lu Y. DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23). Bioengineered. 2022;13(1):1103–1114.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang Y, Li L, et al. Pregnancy-associated plasma protein-A (PAPPA) promotes breast cancer progression. Bioengineered. 2022;13(1):291–307.
   PubMed Web of Science ®Google Scholar
• Hong X, Mao L, Xu L, et al. Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes. Bioengineered. 2022;13(1):995–1012.
   PubMed Web of Science ®Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, et al. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLOS Biol. 2010;8(6):e1000412.
   PubMed Web of Science ®Google Scholar
• Shen J, Wang M, Li F, et al. Homeodomain-containing gene 10 contributed to breast cancer malignant behaviors by activating Interleukin-6/Janus kinase 2/Signal transducer and activator of transcription 3 pathway. Bioengineered. 2022;13(1):1335–1345.
   PubMed Web of Science ®Google Scholar
• Pustchi SE, Avci NG, Akay YM, et al. Astrocytes decreased the sensitivity of glioblastoma cells to temozolomide and Bay 11–7082. Int J Mol Sci. 2020;21(19):7154.
   PubMed Web of Science ®Google Scholar
• Li P, Xiao J, Zhou B, et al. SYNE1 mutation may enhance the response to immune checkpoint blockade therapy in clear cell renal cell carcinoma patients. Aging (Albany, NY). 2020;12(19):19316–19324.
   PubMedGoogle Scholar
• Meng X, Xiong Z, Xiao W, et al. Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression. Ann Transl Med. 2020;8(6):319.
   PubMed Web of Science ®Google Scholar
• Zhu F, Duan W, Zhong C, et al. The protective effects of dezocine on interleukin-1β-induced inflammation, oxidative stress and apoptosis of human nucleus pulposus cells and the possible mechanisms. Bioengineered. 2022;13(1):1399–1410.
   PubMed Web of Science ®Google Scholar
• Feng M, Dong N, Zhou X, et al. Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling. Bioengineered. 2022;13(1):96–106.
   PubMed Web of Science ®Google Scholar
• Kubiliūtė R, Žukauskaitė K, and Žalimas A, et al. Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma. J Cancer Res Clin Oncol. 2021. DOI:10.1007/s00432-021-03837-7.
   PubMed Web of Science ®Google Scholar
• Murdocca M, Torino F, Pucci S, et al. Urine LOX-1 and volatilome as promising tools towards the early detection of renal cancer. Cancers (Basel). 2021;13(16):4213.
   PubMed Web of Science ®Google Scholar
• Arendowski A, Ossoliński K, Ossolińska A, et al. Serum and urine analysis with gold nanoparticle-assisted laser desorption/ionization mass spectrometry for renal cell carcinoma metabolic biomarkers discovery. Adv Med Sci. 2021;66(2):326–335.
   PubMed Web of Science ®Google Scholar
• Huang H, Cui G, Tang H, et al. Relationships between plasma expression levels of microRNA-146a and microRNA-132 in epileptic patients and their cognitive, mental and psychological disorders. Bioengineered. 2022;13(1):941–949.
   PubMed Web of Science ®Google Scholar
• Lee CH, Motzer RJ, Glen H, et al. Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma. Br J Cancer. 2021;124(1):237–246.
   PubMed Web of Science ®Google Scholar
• Pastore AL, Palleschi G, Silvestri L, et al. Serum and urine biomarkers for human renal cell carcinoma. Dis Markers. 2015;2015:251403.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu S, Li Q, et al. The deubiquitylase USP 2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer. Cell Death Differ. 2020;27(9):2710–2725.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhao Y, Sun Y. USP 2 is an SKP2 deubiquitylase that stabilizes both SKP2 and its substrates. J Biol Chem. 2021;297(4):101109.
   PubMed Web of Science ®Google Scholar
• Liu XQ, Shao XR, Liu Y, et al. Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer. Oncogene. 2021;41:502–514.
   PubMed Web of Science ®Google Scholar
• D’Orazi G, Cordani M, Cirone M. Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies. Cell Mol Life Sci. 2021;78(5):1853–1860.
   PubMed Web of Science ®Google Scholar
• Zhang LM, Su LX, Hu JZ, et al. Epigenetic regulation of VENTXP1 suppresses tumor proliferation via miR-205-5p/ANKRD2/NF-kB signaling in head and neck squamous cell carcinoma. Cell Death Dis. 2020;11(10):838.
   PubMed Web of Science ®Google Scholar
• Jadli M, Thakur K, Aggarwal N, et al. Delineating role of NF-κB and interacting cytokines during prostate cancer-induced osteoclastogenesis. J Cell Biochem. 2021;122(2):259–276.
   PubMed Web of Science ®Google Scholar
• Liu W, Wang H, Bai F, et al. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-κB. Cell Prolif. 2020;53(3):e12776.
   PubMed Web of Science ®Google Scholar